D-Wave Quantum Inc. WT

Rigetti Computing, Inc.

NVIDIA Corporation

Quantum computers have the potential to revolutionize medicine, materials science, the management of complex systems like cellular or power grids, and last but not least, <a href="https://oninvest.com/article/nezametnyj-apokalipsis-kakoj-konec-sveta-mogut-ustroit-kvantovye-komp-utery">cryptography</a>. According <a href="https://thequantuminsider.com/2025/07/14/investor-sentiment-pivots-as-funding-ma-and-research-advances-spark-interest-during-q2-2025/#:~:text=Total%20private%20capital%20investment%20in,fewer%20but%20larger%20funding%20rounds.">to</a> Quantum Insider, venture capitalists invested 50% more in the technology in the second quarter of 2025 than in the same period a year earlier. Perhaps in part because many companies have announced that they are beginning to explore the use of quantum computers in the super-hot topic of artificial intelligence. What happens when you combine these two technologies? Is this really a future incredible breakthrough or just hype squared?

Hype squared or breakthrough: Is it time to capitalize on quantum AI 

Country Garden Holdings Company Limited

August 25, 2025 was a symbolic moment for the real estate sector in China - the stock exchange in Hong Kong delisted the company Evergrande, the collapse of which, among other things, began the protracted crisis in the real estate market of China. In 2020, the country's authorities tightened financial requirements for developers and the next year began a relentless decline in housing prices. Because of the crisis in the real estate market, the Chinese economy is slowing down and may fall into a multi-year stagnation. What mistakes led to it?

Ghost towns and huge debts: what the crisis has taught the Chinese real estate market 

Nebius Group N.V.

CoreWeave, Inc.

CoreWeave and Nebius Group have similar businesses. Both companies build full-service infrastructure for AI developers. They share a common partner, Nvidia, which not only supplies them with their AI gas pedals, but also owns stakes in both companies. Both CoreWeave and Nebius have reported impressive Q2 2025 numbers, but investors have taken them differently. Which is something to consider when adding shares of these companies to your portfolio.

CoreWeave vs Nebius Group: why such similar companies will suit different investors

Intel Corporation

The administration of US President Donald Trump has made an unprecedented deal with Intel - the government becomes the owner of almost 10% of the company's shares. This is not the first time that the American authorities have entered into the capital of companies in distress, but it is the first time when there is no economic crisis in the country.

A matter of national security: how Donald Trump is building his version of state capitalism

From August 20 to 24, one of the most outstanding ship festivals Sail Amsterdam took place in Amsterdam. This grandiose event was held for the 10th time, this year it was timed to coincide with the 750th anniversary of the Dutch capital.

How the garden-to-glass philosophy is changing aperitifs

EssilorLuxottica Societe anonyme

Meta Platforms, Inc.

Safilo Group S.p.A.

Last year, the eyewear market was one of the few luxury product categories to show growth, consultancy Bain &amp; Company <a href="https://www.bain.com/insights/luxury-in-transition-securing-future-growth/#:~:text=Eyewear%20expanded%20by%203%25%20to%205%25%20at%20current%20exchange%20rates%20in%202024%2C%20reaching%20%E2%82%AC17%20billion.%20Growth%20was%20fueled%20by%20heightened%20creativity%2C%20trading%20up%20by%20customers%20to%20higher%20price%20segments%2C%20and%20specialized%20brands%20that%20effectively%20catered%20to%20the%20distinct%20preferences%20of%20some%20consumer%20groups.">reckoned </a>. This year, judging by the reporting of public companies in the sector, the trend is continuing.

Keep your eyes open: how AI and nostalgia are driving up eyewear sales 

Apple Inc.

Figma

Nvidia shares lost 3.5% after a weak report on key AI chips and uncertainty over exports to China. Intel warned that having a new shareholder - the US government - could complicate the company's overseas business. Figma's quotes collapsed after neutral Wall Street estimates, analysts consider the company's shares overvalued. Core inflation in the U.S. in July rose at the fastest pace in five months. About the main events from August 25 to 29 - in our review.

Highlights of the week: Nvidia and Figma disappointment, Intel risks, Apple expectations

Shell plc

The year 2025 can hardly be called a calm year for the oil market - the increase in OPEC+ production since the spring of this year has become one of the factors putting pressure on prices. Since April, the member countries of the association have been accelerating their production quotas compared to the plan approved in December 2024. As early as September 2025, they will finally lift production <a href="https://www.opec.org/pr-detail/572-03-august-2025.html">limits of</a> 2.2 million barrels per day. The mood at the July OPEC meeting in Vienna was described by one of its participants in <a href="https://www.ft.com/content/60baf8ed-9652-415d-9a78-51e2c00f686a">a conversation with the FT </a>as similar to "the mood of sailors before the storm".

A fortress company: why banks see Shell as a defensive asset in the oil market

Data

SentinelOne, Inc.

Palo Alto Networks, Inc.

CrowdStrike Holdings, Inc.

The Motley Fool has <a href="https://www.fool.com/investing/2025/09/02/1-no-brainer-ai-stock-down-75-buy-dip-wall-street/">spotlighted</a>&nbsp;mid-cap cybersecurity company SentinelOne as a "no-brainer" AI stock to buy while on the dip. It still trades far below its 2021 high and at some of the cheapest valuations in its sector, even though the company is expanding faster than peers.

Motley Fool spotlights cybersecurity firm SentinelOne as AI stock to buy on the dip

Scholar Rock Holding Corporation

Biogen Pharmachem Industries Ltd

Freedom Broker has issued a short-term trade idea to buy shares of biotech company Scholar Rock ahead of a U.S. regulator’s ruling on the registration of its drug for spinal muscular atrophy (SMA). If approved, analysts said, apitegromab could mark a new era in neuromuscular disease therapy and drive a nearly 40% rise in the stock over the next two months.

SMA drugmaker Scholar Rock may jump on upcoming FDA decision, Freedom Broker thinks

GitLab Inc.

It sees almost 50% upside versus current market quotes on the stock

'Don't sleep on this one': BofA reiterates 'buy' on DevSecOps platform GitLab

Eastman Kodak Company

FUJIFILM Holdings Corporation

Nikon Corporation

Attempts to branch into crypto and pharma have not reversed the decline of the oldest photography company

'Kodak moment': Will nostalgia for film be enough to save Kodak?

Strattec Security Corporation

Freedom Broker has reiterated its "buy" rating while raising&nbsp;its target price&nbsp;by more than 20% on shares of Strattec Security, a small supplier of automotive locks and keys to the likes of Ford, General Motors, and Stellantis, citing expectations of stronger profitability next year despite slowing revenue growth. The new target price of $85 per share offers upside of about 27% above the stock’s August 27 closing price of $66.83 per share.&nbsp;

Freedom Broker raises TP on Ford and GM supplier Strattec Security for 27+% upside

Small Caps

Rising UK bond yields are a signal to London that borrowing will become more expensive

UK bond yields hit a 27-year high. EU bonds are also at their peak

Palantir Technologies Inc.

Bond investors fear that the U.S. will have to pay back funds collected from duties

US stock indexes are down. Why is Trump's possible repeal of duties a bad thing?

Morgan Stanley's Michael Wilson suggests buying back U.S. stocks on drawdowns that may occur amid seasonal weakness on Wall Street

Morgan Stanley strategist, who guessed the dynamics of shares in spring, bets on the continuation of the rally

Deckers Outdoor Corporation

Duty risks do not undermine the brand's long-term story, according to the analyst

Review